Bao Sun | Analytical Chemistry | Best Researcher Award

Dr. Bao Sun | Analytical Chemistry | Best Researcher Award

The Second Affiliated Hospital of Xi’an Medical University, China

👨‍🎓Profiles

🎓 Academic Background

Dr. Bao Sun is currently a full-time Ph.D. candidate at the School of Life Sciences, Northwestern University, a Double First-Class institution. Under the supervision of Professor Zheng Xiaohui, a national talent recognized by the “Hundred Thousand Talents Project,” Dr. Sun is engaged in advanced research in the fields of clinical pharmacology and drug efficacy. He holds a Master’s degree in Pharmacology from Zhengzhou University, also a Double First-Class university, where he studied under Professor Qiao Hailing. His academic journey has been rooted in translational medical research with strong emphasis on drug mechanism and patient-centric therapy.

🏥 Professional Experience

Dr. Sun works at the Second Affiliated Hospital of Xi’an Medical College, where he has served in the Department of Pharmacy with primary responsibilities in clinical pharmacy services and pharmaceutical management. He has undergone clinical pharmacist training at Xijing Hospital, earning a Clinical Pharmacist Certificate issued by the Chinese Medical Association Clinical Pharmacist Branch. His experience bridges academic knowledge with hospital-based application, particularly in optimizing therapeutic strategies for patients.

🧠 Research Focus and Publications

Dr. Sun’s research interests lie in neuropathic pain mechanisms, anti-inflammatory agents, and drug-resistance modulation. He is a co-author of several high-impact papers:

  • “A novel compound DBZ ameliorates neuropathic pain and anxiety-like behaviors in SNI mouse models”, published in Talanta Open (IF = 4.2), explores the PI3K/AKT/Fyn/NMDA signaling pathway.

  • “DBZ alleviates chronic inflammatory pain”, published in Drug Resistance (IF = 4.177), underscores the compound’s therapeutic promise.

  • “A Rare Case of Biliary Cryptococcosis”, a noteworthy clinical observation contributing to case-based medical literature.

  • Contributions to pharmacist-driven treatment models and literature reviews in infection and pharmacological care.

🧪 Technical and Professional Skills

Dr. Sun demonstrates robust capabilities in drug efficacy evaluation, clinical trial collaboration, and pharmacological data interpretation. He applies molecular pharmacology techniques and integrates clinical data with biochemical pathways to improve patient outcomes. He is experienced in multidisciplinary research, coordinating between physicians, pharmacists, and researchers for holistic therapeutic interventions.

📣 Leadership and Service

As the Secretary of the Youth Work Committee of the Shaanxi Pharmaceutical Society, Dr. Sun is responsible for event planning, academic coordination, and inter-organizational engagement. He has organized and delivered nine city-level seminars under the “Multidisciplinary Training Seminar on Drug Clinical Application and Management” program, contributing significantly to regional pharmaceutical education.

🏆 Awards and Recognition

Dr. Sun was honored as an Outstanding Worker by the Shaanxi Pharmaceutical Association. He also received the Third Prize in the “Medicine” TED Speech Competition organized by the Shaanxi Youth Pharmacist Alliance. His academic and public communication skills have been recognized both in scientific and professional platforms.

🌟 Legacy and Future Contributions

With a strong foundation in clinical pharmacology, academic research, and hospital-based pharmacy, Dr. Bao Sun continues to bridge the gap between laboratory research and bedside care. His future goals include contributing to personalized medicine, developing novel analgesics, and enhancing interdisciplinary collaboration in clinical research. His leadership in pharmaceutical education ensures that his influence will extend across both academic and healthcare domains.

📖Notable Publications

  1. A novel compound DBZ ameliorates neuropathic pain and anxiety-like behaviors in SNI mouse model: Role of PI3K/AKT/Fyn/NMDA signal pathway
    Authors: Bao Sun, Le Yang, Saiying Wang, et al.
    Journal: Under Review
    Year: Not yet published

  2. A Novel Compound DBZ Alleviates Chronic Inflammatory Pain and Anxiety-Like Behaviors by Targeting the JAK2-STAT3 Signaling Pathway
    Authors: Bao Sun, M. Wu, Y. Ru, et al.
    Journal: Journal of Biological Chemistry
    Year: 2025 (May 9)

  3. Development of a non-derivatized LC-MS/MS method for simultaneous quantification of ten neurotransmitters in five neuroinflammatory mouse models
    Authors: Bao Sun, Zhaodi Xia, Chen Wang, et al.
    Journal: Talanta Open
    Year: 2025

  4. A Rare Case of Biliary Cryptococcosis: Clinical Pharmacist Participation in Treatment and Pharmaceutical Care and Literature Review
    Authors: Bao Sun, Yingshuang Tang, Dan Chen, et al.
    Journal: Infection and Drug Resistance
    Year: 2023

  5. Hepatoprotective Role of Berberine on Doxorubicin-Induced Hepatotoxicity – Involvement of Cyp
    Authors: Bao Sun, Yue Yang, Mengzi He, et al.
    Journal: Current Drug Metabolism
    Year: 2020

 

Changjin Xu | Analytical Chemistry | Best Researcher Award -1902

Dr. Changjin Xu | Analytical Chemistry | Best Researcher Award

Inner Mongolia Medical University, China

👨‍🎓Profiles

✨ Early Academic Pursuits

Dr. Changjin Xu began his academic journey with a strong foundation in chemical engineering and technology. His undergraduate studies at Inner Mongolia Agricultural University (2010-2014) laid the groundwork for his passion for materials science and applied chemistry. He pursued a Master’s degree in Applied Chemistry at Inner Mongolia University (2014-2017), further refining his expertise in the field. His dedication to research led him to obtain a Ph.D. in Materials Science from Northeastern University (2017-2021), where he conducted in-depth studies on nanomaterials and catalytic performance.

🎓 Professional Endeavors

Since April 2022, Dr. Xu has been serving as a Lecturer at the School of Pharmacy, Inner Mongolia Medical University. His role involves teaching, mentoring students, and conducting high-impact research in materials science and its applications in the pharmaceutical sector.

💪 Contributions and Research Focus

Dr. Xu’s research primarily revolves around nanomaterials synthesis, catalytic performance optimization, and intermetallic compounds. His expertise in micro-arc oxidation preparation has significantly contributed to advancements in catalysis and materials science.

Notable Research Project:

  • National Natural Science Foundation of China (NSFC) General Project (51971059)
    • Title: Micro-arc oxidation preparation and catalytic performance research of precious metal intermetallic compound nanocrystals
    • Duration: 2020-01-01 to 2023-12-31
    • Funding: RMB 600,000
    • Role: Participated in the project, contributing to innovative research in catalytic materials.

🌟 Impact and Influence

Dr. Xu’s research has made notable contributions to the field of materials science and catalysis, with implications in pharmaceutical and chemical engineering applications. His work in nanocrystal synthesis and catalytic efficiency improvement is paving the way for future innovations.

🎉 Academic Citations

Dr. Xu’s publications in high-impact journals have received recognition within the scientific community. His research papers focus on nanostructured materials, surface engineering techniques, and advanced catalysis.

🛠️ Technical Skills

Dr. Xu is proficient in materials characterization techniques, nanomaterial synthesis, catalytic performance analysis, and micro-arc oxidation. His expertise spans multiple advanced methodologies, ensuring his research aligns with global scientific advancements.

👨‍👩‍👦 Teaching Experience

As a lecturer, Dr. Xu actively engages in student mentorship, curriculum development, and research supervision. His ability to integrate real-world applications into academic learning enhances students’ understanding of materials science in pharmaceuticals.

⚖️ Legacy and Future Contributions

Dr. Xu aims to continue his groundbreaking research in nanomaterials and catalysis, expand his collaborative projects, and contribute to the development of new materials for pharmaceutical applications. His commitment to academic excellence and innovation ensures his lasting impact on the scientific community

📖Notable Publications

From FCC to BCC: Engineering Pd nuclearity in the PdCu catalyst to enhance ethylene selectivity in acetylene hydrogenation
Authors: Changjin Xu, Yinglei Liu, Huiqing Guo, Chun Du, Gaowu Qin, Song Li
Journal: Inorganic Chemistry
Year: 2025

Engineering CeO2 configurations to regulate the CuO dispersion and switch pathways of preferential CO oxidation
Authors: Junfang Ding, Changjin Xu, Guilan Fan, Tuya Naren, Yan Wang, Yang Liu, Xiaojun Gu, Limin Wu, Shanghong Zeng
Journal: Applied Catalysis B: Environmental
Year: 2023

Enhancing selectivity for semi-hydrogenation of Ni by periodic isolation in the MM′X structure
Authors: Yinglei Liu, Changjin Xu, Bo Yang, Xiangying Meng, Gaowu Qin, Song Li
Journal: Catalysis Science & Technology
Year: 2023

Carbon-CeO2 interface confinement enhances the chemical stability of Pt nanocatalyst for catalytic oxidation reactions
Authors: Xu Changjin, Zhang Yue, Chen Jing, Li Song, Zhang Yawen, Qin Gaowu
Journal: Science China Materials
Year: 2021

Engineering the epitaxial interface of Pt-CeO2 by surface redox reaction guided nucleation for low temperature CO oxidation
Authors: Xu Changjin, Wu Yutong, Li Song, Zhou Jun, Chen Jing, Jiang Min, Zhao Hongda, Qin Gaowu
Journal: Journal of Materials Science & Technology
Year: 2020